Since we found that high TIMP1 concentration in BM microenvironment impacted the MM patient’s prognosis, we performed an in vitro experiment using recombinant TIMP1 neutralizing anti-TIMP1 antibody and MM cell lines to clarify the role of TIMP1 on MM cells. This evidence concerns the gene TIMP1 and Miyoshi myopathy.